March CEO appointments drew investor attention as companies reset leadership, improve execution, and address strategic challenges.
Leadership Changes
May 16, 2026
Table of Contents
May 15, 2026
Several public companies announced new CEO appointments in March 2026, drawing investor attention as boards moved to reset leadership, improve execution, or stabilize company strategy.
CEO hiring events can move stocks because new leadership often changes how investors view a company’s future direction. The reaction is usually strongest when a company has struggled with weak revenue growth, falling earnings, margin pressure, or poor stock performance before the appointment.
This article focuses on the 10 biggest 1-day stock moves after March CEO hire announcements.
A new CEO can act as a reset signal.
Investors often view CEO appointments as potential catalysts for:
The stock reaction depends on whether investors believe the new CEO has the experience, credibility, and mandate to improve performance.
Price: $3.59
Date: March 3, 2026
1-day impact: +23.20%
Plug Power appointed Jose Luis Crespo as Chief Executive Officer.
Plug Power develops hydrogen fuel cell systems, electrolyzers, hydrogen production assets, and clean energy infrastructure for industrial, mobility, and stationary power customers.
Shares rose 23.20% after the CEO appointment, making Plug Power the strongest positive CEO hire reaction in March. The move suggests investors viewed the leadership change as a possible reset for a company that has faced execution, cash burn, and profitability concerns.
Key details:
Company: Plug Power Inc. (NASDAQ: PLUG)
New CEO: Jose Luis Crespo
Prior role: Not provided
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: +23.20%
Recent company context: Hydrogen company seeking stronger execution and profitability improvement
Price: $16.97
Date: March 4, 2026
1-day impact: +18.65%
Amprius Technologies appointed Tom Stepien as Chief Executive Officer following Dr. Kang Sun’s retirement.
Amprius develops high-energy-density silicon anode lithium-ion batteries used in aviation, drones, electric mobility, and advanced power applications.
Shares rose 18.65% after the CEO appointment. The reaction suggests investors viewed the leadership change as a growth-phase appointment at a company tied to advanced battery technology.
Key details:
Company: Amprius Technologies, Inc. (NYSE: AMPX)
New CEO: Tom Stepien
Prior role: Not provided
Effective date: Not provided
Previous CEO status: Dr. Kang Sun retired
Reason cited: Lead the company’s next growth phase
1-day stock move: +18.65%
Recent company context: Advanced battery company scaling commercialization
Price: $36.71
Date: March 25, 2026
1-day impact: -11.19%
On Holding appointed co-founders David Allemann and Caspar Coppetti as co-CEOs.
On Holding is a Swiss athletic footwear and apparel company known for premium running shoes, performance gear, and lifestyle products.
Shares fell 11.19% after the announcement, the largest negative CEO hire reaction in March. The move suggests investors may have viewed the leadership structure as unclear, unexpected, or less favorable than a single-executive CEO transition.
Key details:
Company: On Holding AG (NYSE: ONON)
New CEO: David Allemann and Caspar Coppetti
Prior role: Co-founders
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: -11.19%
Recent company context: Premium athletic brand facing high growth expectations
Price: $12.46
Date: March 12, 2026
1-day impact: -11.09%
GPGI appointed Graham Robinson as President and CEO of Compo.
GPGI is a public company with operating interests tied to its Compo business.
Shares fell 11.09% after the appointment, suggesting the market wanted more clarity on execution, business direction, or the financial impact of the leadership change.
Key details:
Company: GPGI, Inc. (OTC: GPGI)
New CEO: Graham Robinson
Prior role: Not provided
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: -11.09%
Recent company context: Leadership change at Compo business unit
Price: $4.63
Date: March 19, 2026
1-day impact: -10.13%
Zura Bio appointed Sandeep Kulkarni, M.D., as Chief Executive Officer.
Zura Bio is a clinical-stage biotechnology company developing immunology and inflammation therapies.
Shares fell 10.13% after the CEO appointment. The decline suggests investors may have focused on broader biotech risk, leadership transition uncertainty, or the need for clearer clinical and financing milestones.
Key details:
Company: Zura Bio Limited (NASDAQ: ZURA)
New CEO: Sandeep Kulkarni, M.D.
Prior role: Not provided
Effective date: January 2026
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: -10.13%
Recent company context: Clinical-stage biotech company with pipeline and financing sensitivity
Price: $1.32
Date: March 17, 2026
1-day impact: -9.93%
Neuronetics appointed Dan Reuvers as President and Chief Executive Officer.
Neuronetics is a medical technology company focused on neurostimulation treatments, including transcranial magnetic stimulation systems for mental health disorders.
Shares fell 9.93% after the appointment, suggesting investors may have viewed the leadership transition as tied to ongoing commercial or profitability challenges.
Key details:
Company: Neuronetics, Inc. (NASDAQ: STIM)
New CEO: Dan Reuvers
Prior role: Not provided
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: -9.93%
Recent company context: Medtech company seeking stronger commercial execution
Price: $1.29
Date: March 10, 2026
1-day impact: -8.59%
Robin’s Chairman and CEO, Petros Panagiotidis, was appointed Chairman and Chief Executive Officer of AI OKTO following completion of a spin-off.
Shares fell 8.59% after the leadership update. The negative reaction suggests investors may have viewed the spin-off and CEO appointment as adding uncertainty around strategy, structure, or future execution.
Key details:
Company: Robin / AI OKTO (NASDAQ: RBNE)
New CEO: Petros Panagiotidis
Prior role: Chairman and CEO of Robin
Effective date: Upon completion of the spin-off
Previous CEO status: Not provided
Reason cited: Spin-off leadership appointment
1-day stock move: -8.59%
Recent company context: Corporate restructuring and spin-off transition
Price: $0.93
Date: March 4, 2026
1-day impact: +5.02%
Tivic Health Systems named Michael K. Handley as CEO.
Tivic Health is a bioelectronic medicine company developing non-invasive therapies and technology platforms for health conditions.
Shares rose 5.02% after the appointment. The market reaction suggests investors viewed Handley’s biotech background as potentially useful for the company’s strategic expansion into biopharma.
Key details:
Company: Tivic Health Systems, Inc. (NASDAQ: TIVC)
New CEO: Michael K. Handley
Prior role: Biotech veteran
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Strategic expansion in biopharma
1-day stock move: +5.02%
Recent company context: Small-cap healthcare company pursuing strategic repositioning
Price: $0.86
Date: March 4, 2026
1-day impact: +3.85%
Smith Micro Software named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer as President and Chief Executive Officer.
Smith Micro Software develops software for wireless carriers, mobile devices, family safety, connected devices, and digital lifestyle services.
Shares rose 3.85% after the appointment. The positive reaction suggests investors viewed the move as a continuity appointment from an executive already familiar with operations and finance.
Key details:
Company: Smith Micro Software, Inc. (NASDAQ: SMSI)
New CEO: Tim Huffmyer
Prior role: Chief Operating Officer and Chief Financial Officer
Effective date: Not provided
Previous CEO status: Not provided
Reason cited: Leadership appointment
1-day stock move: +3.85%
Recent company context: Software company seeking operating discipline and execution improvement
Price: $15.60
Date: March 23, 2026
1-day impact: +3.85%
Aurinia Pharmaceuticals appointed Kevin Tang as CEO after the departure of CEO Greenleaf and the executive team.
Aurinia is a biopharmaceutical company focused on therapies for autoimmune diseases, including lupus nephritis.
Shares rose 3.85% after the appointment. The positive move suggests investors viewed Tang’s appointment as a possible reset after a major executive transition.
Key details:
Company: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)
New CEO: Kevin Tang
Prior role: Not provided
Effective date: March 23, 2026
Previous CEO status: CEO Greenleaf and executive team departed
Reason cited: Leadership reset
1-day stock move: +3.85%
Recent company context: Executive team departure and leadership overhaul
Other March CEO hire events included:
Gambling.com Group (NASDAQ: GAMB) — Kevin McCrystle — March 26, 2026
Synchronoss Technologies (NASDAQ: SNCR) — Pat Doran — March 26, 2026
Telo Genomics (OTC: TDSGF) — John Farlinger — March 31, 2026
Bitcoin Depot (NASDAQ: BTM) — Alex Holmes — March 24, 2026
Gladstone Investment (NASDAQ: GAIN) — Robert Marcotte — March 23, 2026
Verde Clean Fuels (NASDAQ: VGAS) — George Burdette — March 20, 2026
Woodside Energy (NYSE: WDS) — Liz Westcott — March 17, 2026
AptarGroup (NYSE: ATR) — Gael Touya — March 17, 2026
Old Republic International (NYSE: ORI) — Meyer Lehman — March 16, 2026
Kering (OTC: PPRUY) — Jean-Marc Duplaix — March 16, 2026
Regis Corporation (NYSE: RGS) — Susan Lintonsmith — March 16, 2026
Repro Med Systems (NASDAQ: KRMD) — Adam Kalbermatten — March 12, 2026
Acuren Corporation (NYSE: TIC) — Ben Heraud — March 12, 2026
Lanvin Group (NYSE: LANV) — Mandy West — March 12, 2026
Toray Industries (OTC: TRYIY) — Teruyuki Sakimon — March 9, 2026
Seaport Entertainment Group (NYSE: SEG) — Matt Partridge — March 4, 2026
Cigna Corporation (NYSE: CI) — Brian Evanko — March 3, 2026
Their 1-day reactions were smaller than the top 10 CEO hire movers.
CEO hires are not automatically bullish.
Risk increases when:
A CEO announcement can create a short-term move, but investors still need evidence of operational improvement.
After a CEO hire, investors typically monitor:
The key question is whether the CEO appointment becomes a real operating reset or just a headline change.
CEO hiring events are leadership catalysts because they can change investor expectations around strategy, execution, and accountability.
The biggest stock reactions usually occur when a new CEO joins a company that has been underperforming and investors believe the appointment can drive a turnaround.
Platforms like LevelFields track CEO hiring events across public companies, helping investors identify when leadership changes have historically led to meaningful stock moves, especially in companies with weak earnings, poor revenue growth, or prior underperformance.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.
AI scans for events proven to impact stock prices, so you don't have to.
LEARN MORE